A vaccine developed to tackle Streptococcus suis, an economically damaging disease endemic in the global pig population, has ...

SK Bioscience has joined a new international effort to advance an updated Zaire ebolavirus vaccine, following a funding agreement between the CEPI and Merck & Co.

A planned U.S.-funded study of a hepatitis B vaccine drew widespread condemnation from researchers. Now the host country says it cannot proceed.

TAMPA, Fla. — Florida’s Department of Health is meeting in Panama City Beach on Friday to discuss potential changes to the state’s vaccine requirements, a proposal that could significantly alter which ...

The new foot-and-mouth disease vaccine developed by researchers at Diamond Light Source is projected to deliver over $1.3 billion in annual benefits and transform global livestock resilience.

In 2025, federal health agencies dismantled precedents in vaccine guidance, fracturing state-federal alignment and fueling concerns about public health guidance. HHS Secretary Robert F. Kennedy Jr.

With further changes to the U.S.’ recommended vaccine schedule likely in the year ahead under Health Secretary Robert F. Kennedy Jr.’s leadership, his agency’s recent scrutiny of one vaccine additive ...

Karolinska Development AB ( (SE:KDEV)) has provided an update. Karolinska Development’s portfolio company SVF Vaccines has signed a non-binding letter of intent for a reverse takeover of Novakand ...

Dr. Céline Gounder, an internist, epidemiologist and infectious disease specialist, is a CBS News medical contributor as well as senior fellow and editor-at-large for public health at KFF Health News.

Moderna announced Thursday it will receive up to $54.3 million from a global vaccine partnership to fund its ongoing research into a potential bird flu mRNA vaccine, helping to recover some of the ...

There may soon be a new way to limit deaths caused by fentanyl. A preventative vaccine for fentanyl exposure is set to begin human trials and could change the landscape of drug overdoses in the U.S.

A vaccine for the lethal Nipah virus is set for phase two trials in a major breakthrough towards preventing deadly outbreaks. Nipah virus is a life-threatening disease that currently has no approved ...